Navigation Links
FlowCardia, Inc. Launches FlowMate(TM) Injector to Optimize Performance of CROSSER(R) CTO Recanalization Catheter
Date:10/6/2009

SUNNYVALE, Calif., Oct. 6 /PRNewswire/ -- FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), has launched the FlowMate Injector, which dramatically simplifies central lumen crossing of CTOs using the CROSSER CTO Recanalization Catheter.

FlowMate provides unparalleled convenience by granting full control of the procedure to a physician via a single foot pedal, which initiates FlowMate's precise saline delivery as well as the Generator which activates the CROSSER Catheter. Fixed injector settings are integrated into the FlowMate adding even greater convenience and ease of use. A single IV pole houses both the FlowMate and Generator allowing for complete system integration.

"This is a significant improvement to the CROSSER CTO Recanalization System and it takes most of the learning curve out of the equation," said Dr. Cezar Staniloae of St. Vincent's Hospital in New York. "Set up is fast and using the new system affords me more time to focus on the patient and specifically, crossing the chronic occlusion with the CROSSER Catheter."

"We are excited to add this important product to our portfolio and to see the benefits to physicians and patients through enhanced CROSSER Catheter performance," said Chris Barys, Chief Operating Officer of FlowCardia. "FlowMate allows for complete CROSSER Catheter system integration and puts the power into the physician's hands, even when faced with the most difficult CTOs."

The CROSSER Catheter is a minimally-invasive endovascular device that utilizes high-frequency, mechanical vibration to facilitate passage through blockages in the peripheral and coronary arteries. It is designed as a frontline therapy to enable central lumen crossing of chronically occluded arteries thereby maximizing physicians' therapeutic options. Over 7,500 CROSSER Catheter procedures have been performed to date by physicians around the world.

About FlowCardia, Inc.

FlowCardia, Inc. is a privately held medical device company established in 2002 to design and manufacture a portfolio of endovascular CTO recanalization products. The CROSSER CTO Recanalization Catheter, steerable support catheters, and Porter guidewires comprise a family of tools which enable physicians to quickly cross chronic total occlusions allowing for subsequent balloon angioplasty, atherectomy, and/or stent placement. Additional information is available on the company's web site at: www.flowcardia.com.

    PR Contact Info:
    Mark Page
    Sr. Director, Marketing
    FlowCardia, Inc.
    408-617-0352 ext. 301

SOURCE FlowCardia, Inc.


'/>"/>
SOURCE FlowCardia, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FlowCardia, Inc. Appoints Chris Barys Senior VP, Sales
2. $16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer
3. Optical Express Launches Television Advertisement for the Cosmetic Clinic
4. Seidman Law Offices of Chicago Launches New Websites for FELA, Railroad Injury, and Civil Rights Claims
5. Mesoone.com Launches Official Portal With Access To Effective And Affordable Mesotherapy Products
6. The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company
7. SAGE launches Genes & Cancer
8. Typhoon Parma: World Vision Launches Relief Efforts in the Philippines, Pre-positions Supplies in Taiwan
9. Crohn's & Colitis Foundation Launches New Web Site to Commence Take Steps Walk Season: Walkers Can Take the Step that Counts Using New Interactive Features
10. As Environmental Regulations Gather on the Horizon, Crothall Services Group Launches Green Initiatives to Assist Hospitals
11. VisionSync Launches a Smart iPhone First Aid App, iMobile Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... hair transplantation therapy, is proud to announce a new informational post on robotic ... procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) can ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced ... February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of ... use behavioral health analytics to improve Medicaid population health management. , ODH will also ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... on tooth replacement options at his office, Antoine Dental Center. Currently, patients can ... $18,499. Some restrictions may apply, but patients can learn more about these offers ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , February 27, 2017 A recent research ... medical marijuana market alone is expected to reach a value of ... along with 28 states have legalized marijuana for medical ... Florida , North Dakota , ... were approved to use the drug in medical applications such as ...
(Date:2/27/2017)... 2017 The Dutch secure mobile ... use at the security level RESTRICTED. The solution thus meets ... for the communication of classified information. ... Sectra and Samsung have a ... smartphone solution. Sectra Tiger/R is developed by Sectra under guidance ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of the ... 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow at ... $2.9 billion by 2025. This industry report analyzes the ... well as regional levels presented in the research scope. The study provides ...
Breaking Medicine Technology: